The popular medications Ozempic and Saxenda from Novo Nordisk are being investigated after three people experienced an increase in thoughts of suicide and self-harm.
The popular medications Ozempic and Saxenda — both made by Novo Nordisk in Denmark — are under investigation after a small number of users experienced an increase in thoughts of suicide and self-harm.
"Having said that, this does need to be carefully addressed because these drugs do affect hormones in the brain, and theThe increased risk of suicidal ideation associated with GLP-1 drugs has been known since the clinical trials, according to Dr.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
EU probes Ozempic, weight-loss drug Saxenda after reports of suicidal thoughtsThe European Medicines Agency (EMA) is investigating Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator flagged three cases of patients thinking about suicide or self-harm.
続きを読む »
Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal ThoughtsEuropean drug regulators are reviewing the risk of thoughts of suicide and self-harm in people taking Ozempic and another weight-loss drug after getting three reports
続きを読む »
EU Investigates Ozempic Maker After Reports Of Suicidal ThoughtsThe Danish pharma giant finds itself under scrutiny once again- this time, from European regulators.
続きを読む »
EU Investigating Ozempic After Suicidal Thoughts ReportedDrugmaker Novo Nordisk will have its weight-loss drugs, including Ozempic, Saxenda and Wegovy, investigated after Iceland’s health regulator flagged three cases of patients reporting suicidal thoughts.
続きを読む »
Popular weight loss drug gets new warningWegovy and Ozempic are brand names for a drug called semaglutide.
続きを読む »
A One-Time Shot for Type 2 Diabetes? A Biotech Company Is On ItFractyl Health is developing a gene therapy alternative to drugs like Ozempic and Wegovy to control blood sugar and body weight without repeated injections.
続きを読む »